Standout Papers
Immediate Impact
1 by Nobel laureates 3 from Science/Nature 77 standout
Citing Papers
Nanomedicine Tumor Targeting
2024 Standout
Immune checkpoint therapy—current perspectives and future directions
2023 StandoutNobel
Works of Paul M. Dodd being referenced
Phase I Evaluation of Sequential Doxorubicin Gemcitabine Then Ifosfamide Paclitaxel Cisplatin for Patients With Unresectable or Metastatic Transitional-Cell Carcinoma of the Urothelial Tract
2000
Long-Term Survival in Metastatic Transitional-Cell Carcinoma and Prognostic Factors Predicting Outcome of Therapy
1999 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Paul M. Dodd | 753 | 137 | 199 | 246 | 10 | 813 | |
| Geralyn Higgins | 887 | 148 | 247 | 261 | 10 | 967 | |
| Alberto G. Ayala | 502 | 229 | 247 | 263 | 9 | 814 | |
| Iwona Skoneczna | 716 | 68 | 232 | 390 | 16 | 926 | |
| W. Meyenburg | 417 | 52 | 86 | 303 | 9 | 804 | |
| Ricardo L. Favaretto | 675 | 35 | 313 | 106 | 22 | 808 | |
| William Martin‐Doyle | 618 | 40 | 121 | 155 | 19 | 709 | |
| Adrian van der Meijden | 708 | 69 | 73 | 114 | 11 | 797 | |
| J. SALVADOR-BAYARRI | 891 | 70 | 115 | 162 | 16 | 964 | |
| Hans‐Martin Fritsche | 913 | 43 | 136 | 195 | 15 | 963 | |
| Benjamin Scoll | 542 | 75 | 323 | 127 | 11 | 917 |
All Works
Loading papers...